The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded ...

The Centers for Medicare and Medicaid Services said late Friday that it would not cover the medications under Medicare’s Part ...

The Centers for Medicare and Medicaid (CMS) announced Friday it will not be finalizing a rule proposed by the Biden ...

The Trump administration on Friday scrapped a Biden administration proposal to have Medicare cover anti-obesity drugs, ...

Health and Human Services Secretary Robert F. Kennedy Jr. has been critical of the drugs, instead placing a focus on ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Trump officials reject Medicare coverage ...

The Centers for Medicare and Medicaid Services (CMS) finalized a Medicare Advantage (MA) rule proposed by the Biden ...

The rise of GLP-1 drugs like Ozempic are changing consumer food waste patterns both at home and in restaurant settings.

Trump administration rejects a Biden plan to expand Medicare coverage of weight-loss drugs such as Zepbound and Wegovy.

A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases ...

More than 7 million people would have gained coverage to the medicine, CMS said when it proposed the rule.

Whether or not you choose to cover weight loss drugs, offering holistic support can make a meaningful difference in employee ...